Because our previous experiments showed that %sO2 measurements from PAI (Figs. 1 and 4) indicate that ITPP can prime TMEs to be immunogenically “hot” (Figs. 2 and 5), and that ITPP can potentiate ICB tumor control (Figs. 3 and 6), we postulated that PAI measurements on the day of initiating treatment are related to tumor control after ITPP and ICB at a later day. This evidence concerns the gene TPP1 and neoplasm.